D2S Pharma SRL
0.5 FTEThe score of D2S Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +16 % Total assets -3 % Headcount (avg FTE) -17 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
D2S Pharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 38,474 € | ||||
| Equity | 424,697 € | ||||
| Cash | 188,504 € | ||||
| EBITDA | 94,312 € | ||||
| Total assets | 582,318 € |
Filed annual accounts
- Year ended 30 Jun 2025filed on 20 Feb 2026
- Year ended 30 Jun 2024filed on 07 Jan 2025
- Year ended 30 Jun 2023filed on 09 Feb 2024
- Year ended 30 Jun 2022filed on 25 Jan 2023
- Year ended 30 Jun 2021filed on 28 Jan 2022
D2S Pharma's financial analysis
- Solvency72.9%sector median: 56.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of D2S Pharma
D2S Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0563.446.868
- VAT number
- BE0563446868
- Peppol
- Registered · 0208:0563446868 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 30 Sep 2014
- Registered office
- 9700 Oudenaarde
- Size
- Micro · 0.5 FTE
- Latest accounts
- 2025 · filed on 20 Feb 2026
- Activity
- Manufacture of basic pharmaceutical products (NACE 21100)
D2S Pharma (SRL) has been based in Oudenaarde since 2014, active in: manufacture of basic pharmaceutical products. For 2025, it reports a net profit of 38,474 € and equity of 424,697 €; its revenue is not published. With 0.5 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 72.9%, above the median of its sector (56.0%).
Companies similar to D2S Pharma
Companies in the same business, of comparable size and area, outside its group.
- Laboratoire DIPO Manufacture of perfume and toilet preparations Etterbeek · balance sheet 24,259 €
- Cerepharma Manufacture of perfume and toilet preparations Ath · balance sheet €1.52m
- Vesale Pharma Woman Health Wholesale of pharmaceutical and medical goods Éghezée · balance sheet 62,158 €
- Medipharm Worldwide Group Manufacture of basic pharmaceutical products Tienen · balance sheet 331,081 €
- Clarethis Manufacture of basic pharmaceutical products Soignies · balance sheet 172,781 €
- Orbitao Wholesale of pharmaceutical and medical goods Maasmechelen · balance sheet 384,076 €
- Groupe Tete Pharmaceutical Manufacture of basic pharmaceutical products Nivelles · balance sheet €1.15m
- Feton International Wholesale of pharmaceutical and medical goods La Louvière · balance sheet €1.39m
Frequently asked questions about D2S Pharma
What is the revenue of D2S Pharma?
D2S Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of D2S Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0563446868 for D2S Pharma, if the company is VAT-registered. Its company number (CBE) is 0563.446.868.
Where is the registered office of D2S Pharma?
According to the CBE register, the registered office of D2S Pharma is in 9700 Oudenaarde.
What is the equity of D2S Pharma?
At the close of the 2025 financial year, the equity of D2S Pharma amounts to 424,697 €, a solvency of 72.9% of total assets.
How many people work at D2S Pharma?
0.5 full-time equivalents on average according to the 2025 social balance sheet.
Who manages D2S Pharma?
The register lists 2 active mandates at D2S Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of D2S Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →